ERJ Podcast
Eur Respir J 2012; 39: E16 | |
Pentraxin-3 in COPD: innocent bystander or amplifier? Mantovani A. Eur Respir J 2012; 39: 795-796 | |
Desmosine, a biomarker for COPD: old and in the way Luisetti M., Stolk J., Iadarola P. Eur Respir J 2012; 39: 797-798 | |
Towards prognostic biomarkers in pulmonary arterial hypertension Cracowski J-L. Eur Respir J 2012; 39: 799-801 | |
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Zumla A., Blasi F., Raviglione M. Eur Respir J 2012; 39: 802-804 | |
Triple therapy in idiopathic pulmonary fibrosis: an alarming press release Wells A.U., Behr J., Costabel U., Cottin V., Poletti V. Eur Respir J 2012; 39: 805-806 | |
European Union Standards for Tuberculosis Care Migliori G.B., Zellweger J.P., Abubakar I., Ibraim E., Caminero J.A., De Vries G., D'Ambrosio L., Centis R., Sotgiu G., Menegale O., Kliiman K., Aksamit T., Cirillo D.M., Danilovits M., Dara M., Dheda K., Dinh-Xuan A.T., Kluge H., Lange C., Leimane V., Loddenkemper R., Nicod L.P., Raviglione M.C., Spanevello A., Thomsen V.Ø., Villar M., Wanlin M., Wedzicha J.A., Zumla A., Blasi F., Huitric E., Sandgren A., Manissero D. Eur Respir J 2012; 39: 807-819 | |
Congenital diaphragmatic hernia Kotecha S., Barbato A., Bush A., Claus F., Davenport M., Delacourt C., Deprest J., Eber E., Frenckner B., Greenough A., Nicholson A.G., Antón-Pacheco J.L., Midulla F. Eur Respir J 2012; 39: 820-829 | |
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Van Pottelberge G.R., Bracke K.R., Pauwels N.S., Vermassen F.E., Joos G.F., Brusselle G.G. Eur Respir J 2012; 39: 830-838 | |
Total desmosines in plasma and urine correlate with lung function Lindberg C.A., Engström G., de Verdier M. Gerhardsson, Nihlén U., Anderson M., Forsman-Semb K., Svartengren M. Eur Respir J 2012; 39: 839-845 | |
Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study Barr R.G., Ahmed F.S., Carr J.J., Hoffman E.A., Jiang R., Kawut S.M., Watson K. Eur Respir J 2012; 39: 846-854 | |
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Liapikou A., Polverino E., Ewig S., Cillóniz C., Marcos M.A., Mensa J., Bello S., Martin-Loeches I., Menéndez R., Torres A. Eur Respir J 2012; 39: 855-861 | |
Clinical presentation and outcome of venous thromboembolism in COPD Bertoletti L., Quenet S., Mismetti P., Hernández L., Martín-Villasclaras J.J., Tolosa C., Valdés M., Barrón M., Todolí J.A., Monreal M., the RIETE Investigators Eur Respir J 2012; 39: 862-868 | |
Physiological changes during low- and high-intensity noninvasive ventilation Lukácsovits J., Carlucci A., Hill N., Ceriana P., Pisani L., Schreiber A., Pierucci P., Losonczy G., Nava S. Eur Respir J 2012; 39: 869-875 | |
Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze Kusel M.M.H., Kebadze T., Johnston S.L., Holt P.G., Sly P.D. Eur Respir J 2012; 39: 876-882 | |
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010 de Marco R., Cappa V., Accordini S., Rava M., Antonicelli L., Bortolami O., Braggion M., Bugiani M., Casali L., Cazzoletti L., Cerveri I., Fois A.G., Girardi P., Locatelli F., Marcon A., Marinoni A., Panico M.G., Pirina P., Villani S., Zanolin M.E., Verlato G. Eur Respir J 2012; 39: 883-892 | |
Chronic infection and inflammation affect exercise capacity in cystic fibrosis van de Weert-van Leeuwen P.B., Slieker M.G., Hulzebos H.J., Kruitwagen C.L.J.J., van der Ent C.K., Arets H.G.M. Eur Respir J 2012; 39: 893-898 | |
Assessing the Liverpool Respiratory Symptom Questionnaire in children with cystic fibrosis Trinick R., Southern K.W., McNamara P.S. Eur Respir J 2012; 39: 899-905 | |
Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment Martínez-García M-A., Campos-Rodríguez F., Soler-Cataluña J-J., Catalán-Serra P., Román-Sánchez P., Montserrat J-M. Eur Respir J 2012; 39: 906-912 | |
Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea Barceló A., Piérola J., de la Peña M., Esquinas C., Sanchez-de la Torre M., Ayllón O., Alonso A., Agusti A.G.N., Barbè F. Eur Respir J 2012; 39: 913-918 | |
Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction Henzler T., Roeger S., Meyer M., Schoepf U.J., Nance J.W., Haghi D., Kaminski W.E., Neumaier M., Schoenberg S.O., Fink C. Eur Respir J 2012; 39: 919-926 | |
Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries Milara J., Gabarda E., Juan G., Ortiz J.L., Guijarro R., Martorell M., Morcillo E.J., Cortijo J. Eur Respir J 2012; 39: 927-938 | |
Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension Heresi G.A., Tang W.H.W., Aytekin M., Hammel J., Hazen S.L., Dweik R.A. Eur Respir J 2012; 39: 939-944 | |
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre Hurdman J., Condliffe R., Elliot C.A., Davies C., Hill C., Wild J.M., Capener D., Sephton P., Hamilton N., Armstrong I.J., Billings C., Lawrie A., Sabroe I., Akil M., O’Toole L., Kiely D.G. Eur Respir J 2012; 39: 945-955 | |
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India Singla R., Caminero J.A., Jaiswal A., Singla N., Gupta S., Bali R.K., Behera D. Eur Respir J 2012; 39: 956-962 | |
Factors associated with hospital mortality in community-acquired legionellosis in France Chidiac C., Che D., Pires-Cronenberger S., Jarraud S., Campèse C., Bissery A., Weinbreck P., Brun-Buisson C., Sollet J-P., Ecochard R., Desenclos J-C., Etienne J., Vanhems P., the French Legionnaires’ Disease Study Group Eur Respir J 2012; 39: 963-970 | |
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients Mühlethaler K., Bögli-Stuber K., Wasmer S., von Garnier C., Dumont P., Rauch A., Mühlemann K., Garzoni C. Eur Respir J 2012; 39: 971-978 | |
Dietary antioxidants and forced expiratory volume in 1 s decline: the Health, Aging and Body Composition study Bentley A.R., Kritchevsky S.B., Harris T.B., Holvoet P., Jensen R.L., Newman A.B., Lee J.S., Yende S., Bauer D., Cassano P.A. Eur Respir J 2012; 39: 979-984 | |
Breastfeeding is associated with increased lung function at 18 years of age: a cohort study Soto-Ramírez N., Alexander M., Karmaus W., Yousefi M., Zhang H., Kurukulaaratchy R.J., Raza A., Mitchell F., Ewart S., Arshad S.H. Eur Respir J 2012; 39: 985-991 | |
Quantitative assessment of chronic lung disease of infancy using computed tomography Sarria E.E., Mattiello R., Rao L., Tiller C.J., Poindexter B., Applegate K.E., Granroth-Cook J., Denski C., Nguyen J., Yu Z., Hoffman E., Tepper R.S. Eur Respir J 2012; 39: 992-999 | |
Molecular mechanisms of intensive care unit-acquired weakness Bloch S., Polkey M.I., Griffiths M., Kemp P. Eur Respir J 2012; 39: 1000-1011 | |
Prevalence of inappropriate tuberculosis treatment regimens: a systematic review Langendam M.W., van der Werf M.J., Huitric E., Manissero D. Eur Respir J 2012; 39: 1012-1020 | |
Interaction of matrix metalloproteinases with pulmonary pollutants Dagouassat M., Lanone S., Boczkowski J. Eur Respir J 2012; 39: 1021-1032 | |
Towards individualised medicine for airways disease: identifying clinical phenotype groups Travers J., Weatherall M., Fingleton J., Beasley R. Eur Respir J 2012; 39: 1033-1034 | |
Serum neurotrophin-3 and neurotrophin-4 levels are associated with asthma severity in children Szczepankiewicz A., Rachel M., Sobkowiak P., Kycler Z., Wojsyk-Banaszak I., Schöneich N., Skibinska M., Br?borowicz A. Eur Respir J 2012; 39: 1035-1037 | |
Value of s-ACE, BAL lymphocytosis, and CD4+/CD8+ and CD103+CD4+/CD4+ T-cell ratios in diagnosis of sarcoidosis Hyldgaard C., Kaae S., Riddervold M., Hoffmann H.J., Hilberg O. Eur Respir J 2012; 39: 1037-1039 | |
Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC Allibhai Z., Cho B.C.J., Taremi M., Atallah S., Hope A., Hwang D., Keshavjee S., Tsao M., Yasufuku K., Kim S-W., Bezjak A. Eur Respir J 2012; 39: 1039-1042 | |
Tracheobronchial amyloidosis: evidence for local B-cell clonal expansion Borie R., Danel C., Molinier-Frenkel V., Prevot G., Deslee G., Debray M.P., Delfau-Larue M.H., Crestani B. Eur Respir J 2012; 39: 1042-1045 | |
Curing HIV-associated pulmonary arterial hypertension Tcherakian C., Rivaud E., Zucman D., Metivier A-C., Couderc L-J. Eur Respir J 2012; 39: 1045-1046 | |
Home oxygen therapy during natural disasters: lessons from the great East Japan earthquake Kobayashi S., Hanagama M., Yamanda S., Yanai M. Eur Respir J 2012; 39: 1047-1048 | |
Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis Luisetti M. Eur Respir J 2012; 39: 1049 | |
Prescribing and guidelines: both must improve to combat antimicrobial resistance Thomas M., Price D.B., Chisholm A. Eur Respir J 2012; 39: 1050 | |
Is sleep related to cancer in murine models of obstructive sleep disorder? Nozoe K.T., Tufik S., Andersen M.L. Eur Respir J 2012; 39: 1051 | |
Primary lung adenocarcinoma: characteristics by smoking habit and sex Stella G.M., Luisetti M., Pozzi E. Eur Respir J 2012; 39: 1051-1052 | |
Do we always need computed tomography to detect and treat parapneumonic pleural effusion? Sferrazza Papa G.F., Di Marco F., Carlucci P., Colombo L., Mondoni M., Centanni S. Eur Respir J 2012; 39: 1053 | |
Do we always need computed tomography to detect and treat parapneumonic pleural effusion? Moffett B.K. Eur Respir J 2012; 39: 1054 | |
What the pulmonary specialist should know about the new inhalation therapies Mitchell J.P. Eur Respir J 2012; 39: 1054-1055 | |
What the pulmonary specialist should know about the new inhalation therapies Janssens H.M., Laube B.L. Eur Respir J 2012; 39: 1055-1056 | |